Sonnet Biotherapeutics Holdings
SONN · NASDAQ
About SONN
- Employees
- 13
- Headquarters
- Princeton, New Jersey
- Listed
- Jul 27, 2005
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- sonnetbio.com
SONN key statistics
- Market cap
- 8.92M
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 1.71M
- Volume
- 1.18M
- Open price
- $51.58
- High today
- $51.83
- Low today
- $51.00
- 52 Week high
- $5.95
- 52 Week low
- $1.26
Sonnet Biotherapeutics Holdings (SONN) at a glance
As of Nov 20, 2026, Sonnet Biotherapeutics Holdings (SONN) shares are priced at $51.02, giving the company a market cap of 8.92M.
On Nov 20, 2026, the stock traded between $51.00 and $51.83. Its last price was 0.0% above the day's low and 1.6% below its high.
Volume on Nov 20, 2026 reached 1.18M shares, below the average of 1.71M shares a day.
Over the past year Sonnet Biotherapeutics Holdings has ranged from $1.26 to $5.95, and now sits 1061% of the way up that range.
Sonnet Biotherapeutics Holdings met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q3 FY25 it reported -$0.95 per share against an estimate of -$0.4998.
SONN earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 32.7% on average.
- Q4 FY23: reported -$16.72 per share against an estimate of -$33.40
- Q1 FY24: reported -$2.48 per share against an estimate of -$7.34
- Q2 FY24: reported $0.56 per share against an estimate of $1.10
- Q3 FY24: reported -$5.60 per share against an estimate of -$6.24
- Q4 FY24: reported -$3.83 per share against an estimate of -$5.63
- Q1 FY25: reported -$1.56 per share against an estimate of -$1.42
- Q2 FY25: reported -$0.89 per share against an estimate of -$0.9384
- Q3 FY25: reported -$0.95 per share against an estimate of -$0.4998
SONN news
- Press releaseGlobe Newswire
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HBI, BFIN, PBBK, SONN on Behalf of Shareholders
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releasePRNewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: SONN, SKX, FCCO, and SGBG
- Shivdeep Dhaliwal
Palantir, The Trade Desk, Tilray, Sonnet Biotherapeutics, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Similar companies
Companies in the same industry as Sonnet Biotherapeutics Holdings
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+0.00%
- HIRUHiru$0.0004+0.00%
- NVDANVIDIA$125.84−13.80%
- SOXLDirexion Shares ETF Trust$30.88−31.84%
- ANTAnthropic PBC$88.30−9.13%
- NXATNexus Advanced Technologies$0.548+144.97%
- SPDNDirexion Shares ETF Trust$9.41+3.63%
- NIVFNewGenIvf Group$0.0269−23.14%
- TQQQProShares Trust$41.01−16.32%
- SNXXTradr 2X Long SNDK Daily ETF$1.76−31.52%
- AEFIAmerican EcoFuels$0.0005−16.67%
- INTCIntel$51.37−7.82%
Newly listed
Companies that went public in the past six weeks
- ANTAnthropic, PBC$88.30−9.13%
- WWBWINDWARD BIO GROUP AG$24.29+1.15%
- VVVVvVARDIS Holding AG$14.55−3.00%
- MDRNModern Mining Technology$2.85+21.28%
- NARANarragansett Bancorp$10.07−0.69%
- ASPEAspen Neuroscience$12.56+1.37%
- BBTXBambusa Therapeutics$16.00+2.89%
- GBCGEORGIA BANKING$34.25+0.91%
- BHAIUBHAV Acquisition Corp II$10.04+0.20%
- SCQCUSPACCircle Acquisition$10.02+0.10%
- LYCALycia Therapeutics$33.07+4.09%
- DAVIDAVION HEALTHCARE$0.9001−9.99%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.